These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7071571)

  • 1. [Experimental study of optimal dose interval in antibiotic therapy].
    Gerber AU; Craig WA
    Schweiz Med Wochenschr; 1982 Jan; 112(2):42-5. PubMed ID: 7071571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.
    Widdowson CA; Klugman KP
    Semin Respir Infect; 1999 Sep; 14(3):255-68. PubMed ID: 10501313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?
    Ortega M; Marco F; Soriano A; Gómez J; Almela M; Mensa J
    Int J Antimicrob Agents; 2004 Aug; 24(2):178-80. PubMed ID: 15288318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Lesotho.
    Mthwalo M; Wasas A; Huebner R; Koornhof HJ; Klugman KP
    Bull World Health Organ; 1998; 76(6):641-50. PubMed ID: 10191560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-antibiotic effect and clinical significance].
    Kikuchi K; Shimizu K
    Nihon Rinsho; 1992 May; 50(5):1165-72. PubMed ID: 1507445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic sensitivity of Streptococcus pneumoniae in Tunisia: results of a multicenter study (1998-1999)].
    Mahjoubi-Rhimi F; Kechrid A; Boutiba I; Mezghani S; Kamoun A; Smaoui H; Thabet L; Ben Redjeb S; Hammami A
    Tunis Med; 2003 Mar; 81(3):167-71. PubMed ID: 12793066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Staphylococcal lysotypes and sensitivity to antibiotics. Results interpreted with an electronic computer].
    Piguet JD
    Pathol Microbiol (Basel); 1966; 29(5):531-42. PubMed ID: 5181054
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic resistance: an always present problem].
    Debbia EA
    Recenti Prog Med; 1999 Oct; 90(10):505-9. PubMed ID: 10592734
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
    Gagnon RF; Richards GK; Kostiner GB
    Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile delivery of amoxicillin against Streptococcus pneumoniae.
    Cha R; Rybak MJ
    J Antimicrob Chemother; 2004 Dec; 54(6):1067-71. PubMed ID: 15486084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic usage in Taiwan.
    Hsueh PR
    Clin Microbiol Infect; 2005 Nov; 11(11):925-7. PubMed ID: 16216110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
    Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe.
    Bruinsma N; Kristinsson KG; Bronzwaer S; Schrijnemakers P; Degener J; Tiemersma E; Hryniewicz W; Monen J; Grundmann H;
    J Antimicrob Chemother; 2004 Dec; 54(6):1045-50. PubMed ID: 15531598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro susceptibility of streptococcus pneumoniae strains isolated from lower respiratory infections in Instituto Nacional del Tórax (INT)].
    Soler T; Salamanca L; Arbo G; Molina E
    Rev Med Chil; 2002 Mar; 130(3):304-8. PubMed ID: 12043373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.